Multiple myeloma is a complex blood cancer that affects plasma cells in the bone marrow. Treatment typically involves a combination of medicines tailored to each patient’s disease stage, health status, and response to therapy. If you or a loved one has been diagnosed, understanding the range of available medications – and their costs – can help guide more informed treatment decisions.

What is multiple myeloma?

Multiple myeloma is a cancer of plasma cells, which are a type of white blood cell responsible for producing antibodies. When these cells grow uncontrollably, they accumulate in the bone marrow, crowd out healthy cells, and release abnormal proteins that damage bones and organs. There’s currently no cure, but advances in drug therapies have significantly improved survival and quality of life.

Types of medicines used to treat multiple myeloma

Immunomodulatory drugs (IMiDs)

These drugs work by stimulating the immune system to recognize and attack cancerous plasma cells.

• Revlimid (lenalidomide). Often used in both frontline and maintenance therapy. It enhances T-cell and NK-cell responses while directly inhibiting cancer cell growth.
• Pomalyst (pomalidomide). Used when Revlimid is no longer effective.
• Thalomid (thalidomide). Older IMiD with more side effects, used less frequently today.

Generic lenalidomide is available at a fraction of the cost. We’ll break that down in the cost section below.

Proteasome inhibitors

These drugs block proteasomes – cellular complexes that break down proteins – leading to cancer cell death.

• Velcade (bortezomib). Typically used in initial treatment combos. Given via injection.
• Kyprolis (carfilzomib). Used in relapsed or refractory cases.
• Ninlaro (ixazomib). An oral option for patients needing a more convenient regimen.

Monoclonal antibodies

These lab-made antibodies target specific markers on cancer cells, helping the immune system destroy them.

• Darzalex (daratumumab). Targets CD38, a protein found on myeloma cells.
• Sarclisa (isatuximab). Another CD38-targeting antibody.
• Empliciti (elotuzumab). Works by activating immune cells to attack SLAMF7-positive myeloma cells.

Steroids

Used in almost every treatment regimen to reduce inflammation and kill myeloma cells.

• Dexamethasone
• Prednisone

These help boost the effectiveness of other myeloma therapies.

Chemotherapy agents

Traditional chemo drugs are used during stem cell transplant prep or in high-risk cases.

• Melphalan
• Cyclophosphamide

These work by damaging DNA in rapidly dividing cells, including myeloma cells.

Targeted therapies

These newer drugs interfere with specific molecules or pathways involved in cancer growth.

• Xpovio (selinexor). Blocks export of tumour suppressor proteins.
• Farydak (panobinostat). Inhibits histone deacetylase enzymes, affecting gene expression in cancer cells.

CAR-T cell therapy and bispecific antibodies

Used for patients who’ve relapsed multiple times.

• Abecma (ide-cel) and Carvykti (cilta-cel). Custom-engineered T-cells designed to attack BCMA-positive myeloma cells.
• Tecvayli (teclistamab). A bispecific T-cell engager that connects immune cells to myeloma cells.

Common treatment combinations by stage

Initial (induction) therapy

Typically a 3-drug combo:
RVd = Revlimid + Velcade + Dexamethasone

Stem cell transplant (for eligible patients)

High-dose melphalan followed by autologous stem cell transplant.

Maintenance therapy

Revlimid is the go-to choice to keep the disease in remission. Taken orally over months or years.

Relapsed or refractory disease

Monoclonal antibodies, CAR-T therapy, and other novel agents come into play.

Cost of multiple myeloma medicines: branded vs generic

Drug prices vary dramatically between countries, and even more between branded and generic options.

Here’s a comparison of monthly costs for 25mg Revlimid (28 capsules) vs Lenalid (generic lenalidomide, 30 capsules):

Generic lenalidomide is available in the following strengths and costs

• Lenalidomide 5mg (30 capsules): $65 → $2.17 per pill
• Lenalidomide 10mg (30 capsules): $90 → $3.00 per pill
• Lenalidomide 15mg (30 capsules): $110 → $3.67 per pill
• Lenalidomide 25mg (30 capsules): $140 → $4.67 per pill

That’s a massive 95%+ savings compared to the US brand price. This price difference is crucial for uninsured patients and those with high co-pays.

Common side effects of myeloma medicines

Each class of medicine has its own risk profile. Here’s a summary:

Doctors often adjust doses or combine drugs to minimize side effects while maintaining treatment effectiveness.

Recent approvals and advances (2024–2025)

• Carvykti received expanded FDA approval for earlier-line use
• Tecvayli and Talvey continue showing promise in relapsed cases
• Oral bispecifics are in clinical trials for easier delivery
• Generic lenalidomide is now widely accessible online for eligible patients

Financial support and affordable access

Treatment affordability remains a major barrier for many patients. Fortunately, several assistance programs and affordable sources exist:

• Manufacturer co-pay assistance: For Revlimid, Pomalyst, and Darzalex
• Non-profits: Leukemia & Lymphoma Society, PAN Foundation
• Generics: LenalidomideCost.com offers all strengths of Lenalid at $65–$140/month
• International pharmacies: For eligible patients under proper medical guidance

Always speak with your oncologist or haematologist before switching medications or sourcing from outside the US.

Final thoughts

The treatment journey for multiple myeloma is unique for every patient. Whether you’re starting induction therapy, entering maintenance, or managing relapse, there’s a growing arsenal of effective drugs available today.

While branded therapies remain expensive, especially without insurance, generic alternatives like Lenalid offer the same active ingredient at a fraction of the cost. With the right support team – including doctors, pharmacists, and patient advocates – you can build a treatment plan that’s not only medically sound but also financially sustainable.

Ellen Diamond, a psychology graduate from the University of Hertfordshire, has a keen interest in the fields of mental health, wellness, and lifestyle.